Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Xiao-Xia Yina

Xiao-Xia Yina

Guangzhou University, China China

R G Pestell

R G Pestell

Pennsylvania Cancer and Regenerative Medicine Center USA

Nandini N.M

Nandini N.M

JSSAHER, India India

Jiawei Li

Jiawei Li

Auckland University of Technology, New Zealand Newzealand

Sirin	Adham

Sirin Adham

Sultan Qaboos University Oman



Centre National d’Oncologie, Mauritania Mauritania

Rabbia Khan

Rabbia Khan

American College of Surgeons United Arab Emirates

Partha Roy

Partha Roy

GITAM University India

Breast Cancer Summit 2024

About US

Event: 14th World Congress on Breast Cancer Research & Therapies
Date: February 15-17, 2024
Location: Rome, Italy

About us:

Welcome to the 14th World Congress on Breast Cancer Research & Therapies, a pioneering global platform dedicated to advancing the frontiers of breast cancer research, treatment, and patient care. Scheduled to take place from February 15th & 16th, 2024, in the captivating city of Rome, Italy, this conference brings together leading experts, oncologists, researchers, clinicians, and healthcare professionals from around the world.

Our Mission:

At the 14th World Congress on Breast Cancer Research & Therapies, our mission is clear: to foster collaboration, innovation, and knowledge exchange among professionals committed to eradicating breast cancer. With breast cancer being one of the most prevalent and impactful diseases globally, our congress aims to address its multifaceted challenges through cutting-edge research, multidisciplinary discussions, and breakthrough therapeutic approaches.

Key Objectives:

Our congress is dedicated to achieving the following key objectives:

  • Knowledge Exchange
  • Collaboration
  • Patient-Centric Focus
  • Education and Training
  • Awareness and Advocacy

Congress Highlights:

Plenary Sessions: Engage with renowned experts delivering keynote presentations on the latest trends, challenges, and advancements in breast cancer research and therapies.

Scientific Sessions: Explore a diverse range of topics spanning genetics, molecular biology, treatment modalities, survivorship, and more.

Interactive Workshops: Participate in hands-on workshops focused on practical skills, new technologies, and innovative approaches in breast cancer research and care.

Poster Presentations: Discover cutting-edge research through dynamic poster sessions, encouraging lively discussions and idea sharing.

Networking Opportunities: Connect with peers, collaborators, and industry representatives in a vibrant environment conducive to knowledge exchange and partnership building.

Target Audience:

  • Medical Professionals
  • Researchers and Scientists
  • Radiation Oncologist
  • Medical Oncologist
  • Breast Care Nurse
  • Surgeon
  • Reconstructive (plastic) Surgeon
  • Lymphoedema Therapist
  • Breast Cancer Surgeons, Pathologists
  • Patient Advocates and Support Groups
  • Pharmaceutical and Biotech Professionals
  • Survivors and Patients
  • Medical Industry Representatives

Sessions & Tracks

The Breast Cancer Summit 2024 aims to provide optimal healthcare and well-being for young women and girls, concentrating on preventing, diagnosing, and addressing Breast Cancer, along with its associated fields such as Genetics, Pathophysiology, Epidemiology, and Clinical Reports.

Track 1: Breast Cancer:

Breast cancer is a complex and prevalent disease characterized by the uncontrolled growth of cells within the breast tissue. It affects both men and women, with women being more commonly diagnosed. Early detection plays a crucial role in improving outcomes. Regular self-examinations, clinical screenings, and mammograms aid in identifying potential abnormalities at an early, more treatable stage.

Breast cancer can be categorized based on its receptors—hormone receptor-positive (HR+), HER2-positive, and triple-negative. Each subtype demands tailored treatment approaches, including surgery, chemotherapy, radiation, targeted therapy, and hormonal therapy. Researchers and medical professionals continue to make strides in understanding the disease, comprehensive care, early intervention, and collaborative efforts remain vital in the fight against breast cancer.

  • Chemotherapy
  • Malignancy
  • Radiation Therapy

Track 2: Immunotherapy and Breast Cancer:

Immunotherapy, a groundbreaking approach harnessing the body's immune system to fight cancer, is making remarkable strides in breast cancer treatment. By stimulating immune cells to recognize and attack cancer cells, immunotherapy offers new hope in combating this prevalent disease. Immunotherapy's potential to provide durable responses and transform the breast cancer landscape is undeniable. As ongoing research refines its applications, the future holds promise for more effective, precise, and less invasive breast cancer treatments.

  • Immune Checkpoint Inhibitors in Breast Cancer Treatment
  • Immunomodulatory Approaches to Enhance Anti-Tumor Response

Track 3: Breast Cancer treatment:

Not all young women with breast cancer will require chemotherapy, but there are various situations where chemotherapy may be recommended. Breast cancer treatment involves a range of strategies designed to target and eliminate cancer cells. Key approaches include Surgery, Radiation Therapy, Chemotherapy, Hormone Therapy, Targeted Therapy, Immunotherapy, Precision Medicine, Clinical Trials. Treatment plans are personalized, often combining methods for optimal results. Collaborative decision-making ensures informed choices for each patient's journey to recovery.

  • Adjuvant Chemotherapy
  • Neoadjuvant Chemotherapy
  • Advanced Breast Cancer

Track 4: Mastectomy:

Mastectomy is a pivotal surgical procedure in breast cancer treatment. It involves the removal of the affected breast tissue to eradicate or prevent the spread of cancer. Mastectomy decisions are influenced by factors such as tumor size, location, and patient preference. Advances in surgical techniques and reconstruction options aim to improve both physical and emotional well-being post-surgery. Comprehensive discussions between patients and healthcare teams ensure informed choices for a smoother recovery and renewed confidence. Depending on the case, different types of mastectomy may be recommended:

  • Total Mastectomy
  • Modified Radical Mastectomy
  • Skin-Sparing Mastectomy
  • Nipple-Sparing Mastectomy

Track 5: Breast Cancer Surgery:

Breast cancer surgery is a common treatment option for individuals diagnosed with breast cancer. The main goals of breast cancer surgery are to remove the cancerous tissue, determine the extent of the disease, and sometimes, to assess the lymph nodes for any signs of cancer spread. It's important to note that surgery is often just one part of the treatment plan for breast cancer. Depending on the stage and characteristics of the cancer, other treatments like chemotherapy, radiation therapy, hormone therapy, targeted therapy, and immunotherapy might also be recommended.

  • Lumpectomy
  • Sentinel Lymph Node Biopsy
  • Reconstructive Surgery
  • Axillary Lymph Node Dissection

Track 6: Metastatic Breast Cancer:

Metastatic breast cancer, also known as stage IV or advanced breast cancer, is a type of breast cancer that has spread from the breast to other parts of the body, such as the bones, liver, lungs, or brain. In metastatic breast cancer, the cancer cells have traveled through the bloodstream or lymphatic system from the original tumor site in the breast to distant sites in the body. Metastatic breast cancer is considered incurable, but it can often be managed and treated to help control the growth of the cancer, relieve symptoms, and improve the person's quality of life.

  • Immunotherapy
  • Radiation Therapy
  • Palliative Care
  • Hormone Therapy

Track 7: Breast Cancer Radiation Therapy:

Breast cancer radiation therapy, also known as radiotherapy, is a common treatment option used to target and destroy cancer cells in the breast tissue after surgery (such as lumpectomy or mastectomy) or to help alleviate symptoms in cases of metastatic breast cancer. Radiation therapy uses high-energy rays to damage the DNA of cancer cells, preventing them from growing and dividing. While radiation therapy is generally well-tolerated, it can lead to side effects, which may include fatigue, skin changes (like redness or irritation in the treated area), and, in some cases, breast tissue changes. These side effects are typically temporary and can be managed with appropriate care and guidance from the healthcare team.

  • External Beam Radiation Therapy
  • Internal Radiation (Brachytherapy)

Track 8: Breast Cancer Therapies:

Breast cancer therapies encompass a range of treatment options that can be tailored to the type, stage, and characteristics of the breast cancer, as well as the individual's overall health and preferences. These therapies aim to eliminate or control the cancer cells, prevent recurrence, and improve the person's quality of life. The specific treatment plan will depend on factors such as the stage of cancer, hormone receptor status, HER2 status, overall health, and patient preferences. Treatment plans may also involve a combination of these therapies. It's important for individuals with breast cancer to have open and detailed discussions with their healthcare team to make informed decisions about the most suitable treatment approach.

  • Sentinel Lymph Node Biopsy
  • Axillary Lymph Node Dissection

Track 9: Breast Cancer - Clinical Trails:

Clinical trials play a crucial role in advancing medical knowledge and improving treatment options for breast cancer. Clinical trials are research studies that involve volunteers and aim to test new interventions, treatments, drugs, or medical procedures to determine their safety and effectiveness. Participating in a clinical trial can provide individuals with access to cutting-edge treatments that may not yet be widely available and contribute to the development of new therapies.

  • Metastatic and Advanced Disease
  • Personalized Medicine
  • Prevention and Risk Reduction

Track 10: Breast Cancer during pregnancy:

Breast cancer during pregnancy is a rare occurrence, but it can be a complex and challenging situation for both the mother and the medical team. The diagnosis and treatment of breast cancer during pregnancy need to carefully consider the health and well-being of both the mother and the developing fetus. The goal is to provide the best possible outcomes for both the mother and the baby. Open communication between the patient, healthcare team, and specialists is crucial to making informed decisions and ensuring the best possible care for both the mother and the developing fetus.

  • Fetal Monitoring
  • Breastfeeding
  • Diagnosis
  • Multidisciplinary Team

Track 11: Male Breast Cancer Research:

Male breast cancer is a rare condition compared to breast cancer in females, but it's important to recognize that men can also be affected by this disease. Research into male breast cancer helps to understand its causes, risk factors, treatment options, and outcomes. As with any medical research, collaboration between researchers, healthcare professionals, patients, and advocacy groups is essential for advancing our understanding of male breast cancer.

  • Epidemiology and Risk Factors
  • Genetics and Biomarkers
  • Health Disparities

Track 12: Mammography:

Mammography is a widely used medical imaging technique that involves using low-dose X-rays to create detailed images of the breast tissue. It is primarily used for breast cancer screening and early detection. Mammograms can detect small abnormalities in the breast tissue, including those that cannot be felt during a clinical breast exam. Early detection through regular mammograms and other screening methods can significantly increase the chances of successful treatment and recovery from breast cancer.

  • Screening Mammography
  • Diagnostic Mammography

Track 13: Reconstruction of Breast Cancer:

Breast reconstruction is a surgical procedure aimed at rebuilding the breast after it has been removed due to cancer (mastectomy) or damaged by other treatments. It's an option for individuals who have undergone a mastectomy and want to restore the appearance of their breast(s). Breast reconstruction can be performed at the same time as the mastectomy (immediate reconstruction) or as a separate procedure later on (delayed reconstruction). It's important to have open and thorough discussions with healthcare providers to explore the various options and make an informed choice that aligns with individual needs and goals.

  • Implant-Based Reconstruction
  • Autologous Tissue (Flap) Reconstruction

Track 14: Prevention of Breast cancer:

While it's not always possible to prevent breast cancer entirely, there are several lifestyle choices and strategies that can help reduce the risk of developing the disease. Regular screenings, self-exams, and maintaining a healthy lifestyle are essential components of breast health.

  • Maintain a Healthy Weight
  • Avoid Hormone Replacement Therapy
  • Regular Screening
  • Limit Exposure to Environmental Toxins

Track 15: Chemotherapy for Breast Cancer:

Chemotherapy is a systemic treatment that uses drugs to target and destroy rapidly dividing cancer cells throughout the body. It is commonly used in the treatment of breast cancer to shrink tumors, prevent cancer from spreading, and destroy any cancer cells that may remain after surgery. Chemotherapy might also be used in combination with other treatments, such as surgery, radiation therapy, hormone therapy, and targeted therapy.

  • Effectiveness and Monitoring
  • Management of Side Effects
  • Psychological Support

Market Analysis

Breast Cancer Therapeutics Market size was valued at USD 24.2 Billion in 2021 and is projected to reach USD 53.72 Billion by 2030, growing at a CAGR of 8.3% from 2022 to 2030. Breast cancer is a cancer that forms in the cells of the breasts. Breast cancer can occur in women and rarely in men. The symptoms of the breast cancer include a lump in the breast, bloody discharge from the nipple, changes in shape and size of the nipple or breast. There are 2 types of breast cancer: Non-invasive cancers stay within the milk ducts or lobules in the breast. They do not grow or invade in normal tissues within or beyond the breast. Non-invasive cancers are called as carcinoma in situ (in the same place) or pre-cancers. Invasive cancers do grow in normal, healthy tissues. Most breast cancers are invasive. Depending upon the type of cancer the treatment is determined, i.e., whether it is invasive or non-invasive cancer. Treatment varies depending upon the stage of cancer. It may consist of chemotherapy, surgery or radiation.

Early detection of breast cancer greatly increases the chances of successful treatment and saves the life. There are 2 major components of early detection of breast cancer: educate to promote early diagnosis and screening. There are 3 different types of screening tests available; they are the mammogram, clinical breast exam (CBE) and MRI (magnetic resonance imaging).

The increasing prevalence of breast cancer due to certain factors such as prolonged exposure to endogenous estrogens, late age at first childbirth, early menarche, and late menopause are driving the growth of the Global Breast Cancer Therapeutics Market during the forecast period. The Global Breast Cancer Therapeutics Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors playing a substantial role in the market.


Global Breast Cancer Therapeutics Market Overview

The Global Breast Cancer Therapeutics Market is expected to experience remarkable growth in the upcoming years owing to the increasing prevalence of the disease, particularly in developed countries, which will drive the growth of the Breast Cancer Therapeutics Market. Breast cancer is the second-most common type of cancer worldwide (whereas lung cancer is the first) and is frequently diagnosed cancer in women, according to World Health Organization statistics.

Huge costs associated with breast cancer therapeutics, increasing costs of early and late-stage disease therapy, and side effects associated with breast cancer drugs are expected to hinder the growth of the Global Breast Cancer Therapeutics Market throughout the forecast period.

Global Breast Cancer Therapeutics Market: Segmentation Analysis

Survey Report

Breast cancer is the second leading cancer in women worldwide, with nearly 1.7 million new cases diagnosed in 2012. Breast cancer is most common after menopause. American Cancer Society, for the year 2016 estimates that about 252,710 new cases of invasive breast cancer will be diagnosed in women, about 63,410 new cases of carcinoma in situ (CIS) will be diagnosed and about 40,601 women will die from breast cancer.

Past Conference Report

Conference Series takes a great pride in announcing the commencement of 13th World Congress on Breast Cancer Research & Therapies which was held during June 12-13, 2023 a webinar.

Breast Cancer Summit 2023 has received a benevolent response from all over the world. This has been conducted with the aim and the categorical intent of promoting the developments of new perceptions and ideas for exploring the high level of knowledge reached by scientific community.

The conference aimed a parallel rail with theme “Delving into the Advances in Breast Cancer Research”. The conference witnessed an amalgamation of peerless speakers, who enlightened with their enviable research knowledge and on various alluring topics related to the Breast cancer field. The highlights of the conference were the keynote forum by prominent scientists, of which the following topics were highlighted:

Title: Immune Oncology Therapy for Breast Cancer: CCR5 Inhibitors Enhance Breast Cancer Cell Killing and Reduce Doxorubicin-Induced Cardiotoxicity.
R G. Pestell, Pennsylvania Cancer and Regenerative Medicine Center USA

Title: Breast cancer cytology and ancillary techniques in Low Middle Income Group Countries (LMIC) like India.
Nandini N.M, JSSAHER, India

Title: Faster Boundary-aware Transformer for Breast Cancer Segmentation.
Xiao-Xia Yin, University of Guangzhou, China

The success of 13th World Congress on Breast Cancer Research & Therapies has given us the prospect to bring the gathering at one place in Rome, Italy and meet after this long pandemic. Conference Series hosting 14th World Congress on Breast Cancer Research & Therapies on February 15-16, 2024, in Rome, Italy.

Mark your calendars for the upcoming extravaganza; we are hoping to see you soon In person!

Let us meet again @ Breast Cancer Summit 2024
Contact details.

To Collaborate Scientific Professionals around the World

Conference Date February 15-16, 2024

For Sponsors & Exhibitors

Speaker Opportunity

Past Conference Report

Supported By

Breast Cancer: Current Research Journal of Womens Health, Issues and Care Cancer Science & Therapy

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by

Media partners & Collaborators & Sponsors


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner